DIN 02542307 — EPKINLY 60 MG
EPKINLY is a solution of Epcoritamab marketed by ABBVIE CORPORATION. The full Epcoritamab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02542307
- Brand name
- EPKINLY
- Active ingredient
- Epcoritamab
- Strength
- 60 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Bispecific CD20xCD3 T-cell engaging antibody (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Epcoritamab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02542293 | EPKINLY | 5 MG | SOLUTION | ABBVIE CORPORATION | MARKETED |